Company intelligence / Profile preview

Russian Peptide

Saint Petersburg, Russia
Ownership
Private
Employees
~35
Development stage
Other
01

Overview

Russian Peptide is a biotechnology company headquartered in Saint Petersburg, Russia, that specializes in the research, development, and production of peptide-based compounds. The company operates as both a product developer and a contract manufacturing organization, providing high-purity peptides for the pharmaceutical, cosmetic, and research industries. Their extensive portfolio includes bioregulatory peptides such as Epitalon and Semax, which are targeted toward anti-aging, neuroprotection, and metabolic health. Russian Peptide maintains advanced laboratory facilities for custom peptide synthesis, allowing for the creation of complex sequences and modified peptides. By integrating scientific research with industrial production, the company supports the global life sciences community in exploring the therapeutic potential of peptide molecules. Their services also encompass chemical analysis and quality control to ensure the stability and efficacy of their synthesized products.

Therapeutic areas
OtherCardiovascularNeurologyMetabolic DisordersPsychiatryMen's Health
Modalities
Peptides
Industry
Biotech
02

Partnerships

Saint Petersburg Institute of Bioregulation and Gerontology

Beyond the preview

Go deeper on Russian Peptide.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Russian Peptide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call